文献速递主动脉疾病

骨质疏松对腹主动脉瘤腔内修复术后总生存的影响

Impact of osteoporosis on overall survival following endovascular repair for abdominal aortic aneurysms.
PubMed 文献 · J Vasc Surg · 2024-08-30

这项回顾性单中心队列研究纳入2016至2018年间172例因腹主动脉瘤行初次腔内修复术的患者,通过术前CT第11胸椎Hounsfield单位评估骨密度,以<110 HU定义为骨质疏松。中位随访68个月,骨质疏松组总生存显著低于非骨质疏松组,多因素分析显示骨质疏松是全因死亡的独立危险因素(HR 1.76,95%CI 1.01-3.06,P<.05)。作者认为骨质疏松合并症可能有助于估计腹主动脉瘤患者的预期寿命。

要点

  • 172例中骨质疏松72例(41.9%),非骨质疏松100例(58.1%)。
  • 中位随访68个月,骨质疏松组总生存显著低于非骨质疏松组(log-rank P<.05)。
  • 多因素分析显示骨质疏松是全因死亡的独立危险因素(HR 1.76,95%CI 1.01-3.06,P<.05)。

核心结论

  • 骨质疏松患者行EVAR后全因死亡率高于非骨质疏松患者。
  • 作者认为骨质疏松合并症可能有助于估计腹主动脉瘤患者的预期寿命。

研究设计与样本

  • 回顾性、单中心队列研究,纳入2016至2018年间172例因腹主动脉瘤行初次EVAR的患者。
  • 术前CT测量第11胸椎Hounsfield单位评估骨密度,<110 HU定义为骨质疏松。
  • 全部患者分为骨质疏松组与非骨质疏松组,比较长期结局,并用单因素和多因素分析评估各变量对全因死亡的风险比。

主要发现

  • 172例中骨质疏松组72例(41.9%),非骨质疏松组100例(58.1%)。
  • 骨质疏松组平均年龄大于非骨质疏松组(79.2 ± 7.2岁 vs 75.0 ± 8.7岁,P<.05),平均骨密度低于非骨质疏松组(78.1 ± 26.7 HU vs 155.1 ± 36.3 HU,P<.05)。
  • 中位随访68个月,骨质疏松组总生存显著低于非骨质疏松组:5年、7年总生存分别为63.9%和36.7% vs 83.8%和74.6%(log-rank P<.05)。
  • 无动脉瘤相关死亡生存两组无显著差异:骨质疏松组5年、7年分别为94.3%和89.0%,非骨质疏松组分别为100.0%和96.7%(log-rank P = .078)。
  • 多因素分析中,骨质疏松是全因死亡的独立危险因素(HR 1.76,95%CI 1.01-3.06,P<.05),年龄、他汀使用、肌少症和动脉瘤直径也是独立危险因素。

临床怎么用

  • 作者认为骨质疏松合并症可能有助于估计腹主动脉瘤患者的预期寿命。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the impact of osteoporosis on overall survival following endovascular aneurysm repair (EVAR) for abdominal aortic aneurysms (AAAs). METHODS: This was a retrospective, single-center cohort study on 172 patients who had undergone primary EVAR for AAA between 2016 and 2018. Bone mineral density (BMD) was assessed by measuring the Hounsfield units (HUs) of the 11th thoracic vertebra on preoperative computed tomography; a BMD value of <110 HU was considered osteoporosis. All patients were divided into those with osteoporosis and those without osteoporosis, and long-term outcomes were compared. In addition, hazard ratios of each variable for all-cause mortality were evaluated using univariate and multivariate analysis. RESULTS: All 172 patients were divided into two groups: 72 patients (41.9%) with osteoporosis and 100 patients (58.1%) without osteoporosis. The mean age was older and the mean BMD was lower in patients with osteoporosis than patients without osteoporosis (mean, 79.2 ± 7.2 years vs 75.0 ± 8.7 years, respectively; P < .05; 78.1 ± 26.7 HU vs 155.1 ± 36.3 HU, respectively; P < .05). During the median follow-up period of 68 months, overall survival was significantly lower in patients with osteoporosis than patients without osteoporosis (osteoporosis: 63.9% and 36.7% at 5 years and 7 years; nonosteoporosis: 83.8% and 74.6% at 5 years and 7 years, respectively; log-rank P < .05); freedom from aneurysm-related mortality did not differ significantly between groups (osteoporosis: 94.3% and 89.0% at 5 years and 7 years; nonosteoporosis: 100.0% and 96.7% at 5 years and 7 years, respectively; log-rank P = .078). In a multivariate analysis for overall survival after EVAR, coexistence of osteoporosis was found to be an independent risk factor for all-cause mortality (hazard ratio, 1.76; 95% confidence interval, 1.01-3.06; P < .05), as well as variables including age, statin use, sarcopenia, and aneurysm diameter. CONCLUSIONS: Patients with osteoporosis showed a higher all-cause mortality after EVAR than patients without osteoporosis. We believe that comorbidity of osteoporosis may be useful in estimating the life expectancy of patients with AAA.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Ozawa H, Ohki T, Shukuzawa K, et al. Impact of osteoporosis on overall survival following endovascular repair for abdominal aortic aneurysms. J Vasc Surg. 2024. PMID: 39208917. doi:10.1016/j.jvs.2024.08.034

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。